Outcome of initial cord blood transplantation with FM80TBI as conditioning regimen for acute myeloid leukemia.
Saved in:
| Title: | Outcome of initial cord blood transplantation with FM80TBI as conditioning regimen for acute myeloid leukemia. |
|---|---|
| Authors: | Akimoto M; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan., Tachibana T; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan. tachibana.tak.kt@yokohama-cu.ac.jp., Tanaka M; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan., Izumi A; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan., Takeda T; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan., Fujimaki K; Department of Hematology, Fujisawa City Hospital, Fujisawa, Japan., Tamai Y; Division of Hematology, Shonan Kamakura General Hospital, Kamakura, Japan., Sato S; Division of Hematology, Shonan Kamakura General Hospital, Kamakura, Japan., Fujita H; Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan., Suzuki T; Department of Hematology, Kitasato University School of Medicine, Sagamihara, Japan., Yamamoto K; Department of Hematology, Yokohama City Minato Red Cross Hospital, Yokohama, Japan., Yamazaki E; Department of Hematology, Yokohama Rosai Hospital, Yokohama, Japan., Maeda N; Division of Hematology, Department of Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan., Arai S; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan., Hirose N; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan., Nakajima H; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan. |
| Source: | Annals of hematology [Ann Hematol] 2026 Feb 16; Vol. 105 (4), pp. 118. Date of Electronic Publication: 2026 Feb 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41697386 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Outcome of initial cord blood transplantation with FM80TBI as conditioning regimen for acute myeloid leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Akimoto+M%22">Akimoto M</searchLink>; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Tachibana+T%22">Tachibana T</searchLink>; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan. tachibana.tak.kt@yokohama-cu.ac.jp.<br /><searchLink fieldCode="AU" term="%22Tanaka+M%22">Tanaka M</searchLink>; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Izumi+A%22">Izumi A</searchLink>; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Takeda+T%22">Takeda T</searchLink>; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Fujimaki+K%22">Fujimaki K</searchLink>; Department of Hematology, Fujisawa City Hospital, Fujisawa, Japan.<br /><searchLink fieldCode="AU" term="%22Tamai+Y%22">Tamai Y</searchLink>; Division of Hematology, Shonan Kamakura General Hospital, Kamakura, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+S%22">Sato S</searchLink>; Division of Hematology, Shonan Kamakura General Hospital, Kamakura, Japan.<br /><searchLink fieldCode="AU" term="%22Fujita+H%22">Fujita H</searchLink>; Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+T%22">Suzuki T</searchLink>; Department of Hematology, Kitasato University School of Medicine, Sagamihara, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+K%22">Yamamoto K</searchLink>; Department of Hematology, Yokohama City Minato Red Cross Hospital, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Yamazaki+E%22">Yamazaki E</searchLink>; Department of Hematology, Yokohama Rosai Hospital, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Maeda+N%22">Maeda N</searchLink>; Division of Hematology, Department of Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Arai+S%22">Arai S</searchLink>; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Hirose+N%22">Hirose N</searchLink>; Department of Hematology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, 241-8515, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Nakajima+H%22">Nakajima H</searchLink>; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2026 Feb 16; Vol. 105 (4), pp. 118. <i>Date of Electronic Publication: </i>2026 Feb 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41697386 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00277-026-06888-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 118 Titles: – TitleFull: Outcome of initial cord blood transplantation with FM80TBI as conditioning regimen for acute myeloid leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Akimoto M – PersonEntity: Name: NameFull: Tachibana T – PersonEntity: Name: NameFull: Tanaka M – PersonEntity: Name: NameFull: Izumi A – PersonEntity: Name: NameFull: Takeda T – PersonEntity: Name: NameFull: Fujimaki K – PersonEntity: Name: NameFull: Tamai Y – PersonEntity: Name: NameFull: Sato S – PersonEntity: Name: NameFull: Fujita H – PersonEntity: Name: NameFull: Suzuki T – PersonEntity: Name: NameFull: Yamamoto K – PersonEntity: Name: NameFull: Yamazaki E – PersonEntity: Name: NameFull: Maeda N – PersonEntity: Name: NameFull: Arai S – PersonEntity: Name: NameFull: Hirose N – PersonEntity: Name: NameFull: Nakajima H IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 02 Text: 2026 Feb 16 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-0584 Numbering: – Type: volume Value: 105 – Type: issue Value: 4 Titles: – TitleFull: Annals of hematology Type: main |
| ResultId | 1 |